Medicine & Life Sciences
(R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide
16%
1-(4-methoxybenzyl)-5-(trifluoromethoxy)indoline-2,3-dione
16%
AC1903
17%
Acetamides
13%
Aedes
19%
Alzheimer Disease
11%
Amides
10%
Amyloid Precursor Protein Secretases
12%
Antiparkinson Agents
10%
Bone Morphogenetic Proteins
23%
Brain
18%
Catalepsy
11%
choline transporter
11%
Clinical Trials
11%
Culicidae
23%
Dopamine Antagonists
23%
Dopamine Receptors
17%
dorsomorphin
21%
Ether
11%
G Protein-Coupled Inwardly-Rectifying Potassium Channels
17%
GTP-Binding Proteins
24%
Insecticides
15%
Inwardly Rectifying Potassium Channels
54%
Lead
18%
Libraries
10%
Ligands
14%
Major Depressive Disorder
10%
metabotropic glutamate receptor 4
100%
metabotropic glutamate receptor 7
17%
Muscarinic Receptors
17%
N-(3-chlorophenyl)picolinamide
13%
Neurosciences
70%
Palladium
15%
Parkinson Disease
33%
Pharmaceutical Chemistry
23%
Pharmaceutical Preparations
10%
Pharmacokinetics
20%
Pharmacology
27%
picolinamide
16%
piperidine
17%
Podocytes
13%
Potassium Channels
19%
Pyrazines
17%
Rodentia
17%
Schizophrenia
19%
Structure-Activity Relationship
47%
Therapeutics
14%
Transient Receptor Potential Channels
15%
verticilide
17%
Vu0418506
17%
Chemical Compounds
Acetamide
11%
Agent Interacting With Transmitter, Hormone or Drug Receptor
16%
Agonist
19%
Analgesic
7%
Antagonist
35%
Antineoplastic Antibiotic
9%
Antiparkinson Agent
11%
Asenapine
6%
Atypical Antipsychotic Agent
8%
Calcitonin Gene Related Peptide Receptor Antagonist
6%
Cation
7%
Chemistry
9%
Choline
7%
Disorder
25%
DMH1
17%
Dofetilide
6%
Dopamine
19%
Dorsomorphin
18%
Drug
11%
Ezogabine
7%
Glycine Transporter 1 Inhibitor
6%
Haloperidol
7%
Heteroannulation
16%
High Throughput Screening
13%
Iloperidone
6%
Insecticide
7%
Lorcaserin
7%
Microwave Heating
7%
Milnacipran
6%
Molecule
33%
Morphine
8%
Mutation
6%
Parasympathomimetic Agent
23%
Peroxisome Proliferator Activated Receptor Gamma Antagonist
7%
Pharmaceutical
6%
Pharmacokinetics
16%
Picolinamide
12%
Piperidine
8%
Potassium Channel Stimulating Agent
28%
Probe
10%
Pyrazines
13%
Second Generation Antipsychotic
7%
Serotonin
15%
Structure-Activity Relationship
33%
Sulfonamide
8%
Suvorexant
6%
Tryptase Inhibitor
12%
Vilazodone
6%
Xanomeline
7%